(Axios) – An FDA advisory panel on Tuesday voted unanimously for a recommendation that the agency adopt a modified flu vaccine for next fall that could make it easier for manufacturers to increase supplies. The big picture: The panel’s recommendation would turn the quadrivalent flu vaccine into a trivalent vaccine — dropping a specific strain that has not been detected since 2020. (Read More)